Sort
1,049,261 grants matching “t cell”
VGF peptide TLQP-21, a novel microglial C3aR1 modulator in Alzheimer's disease
$4,083,855Stephen R Salton · Icahn School Of Medicine At Mount Sinai · RF1 · FY2019 · AG
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$4,083,505Elizabeth Head · University Of California-Irvine · RF1 · FY2022 · AG
South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE)
$4,083,449Lucia Amelia Pirisi-Creek · University Of South Carolina At Columbia · P20 · FY2015 · GM
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
$4,083,010Steven M Wolinsky · Northwestern University At Chicago · U01 · FY2021 · HL
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
$4,081,180Joseph B. Margolick · Johns Hopkins University · U01 · FY2022 · HL
Chemistry Services for the NTP
$4,080,825Brian Burback · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2016 · ES
Cancer Center Support Grant
$4,078,247Douglas Yee · University Of Minnesota · P30 · FY2024 · CA
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$4,078,100Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIC · FY2013 · HL
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$4,077,456Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Molecular Basis of Cholesterol Metabolism
$4,077,363Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2013 · HL
CSHL CANCER CENTER SUPPORT GRANT
$4,077,038Bruce W Stillman · Cold Spring Harbor Laboratory · P30 · FY2013 · CA
All holographic two-photon electrophysiology
$4,076,874Hillel Adesnik · University Of California Berkeley · RF1 · FY2023 · NS
SHIV Env-antibody coevolution as a molecular guide to HIV-1 V3 glycan targeted vaccine design
$4,076,804George M Shaw · University Of Pennsylvania · P01 · FY2024 · AI
Tumor Molecular Sequencing: Cancer Genomics Database
$4,076,719Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA
Omics for TB Disease Progression (OTB)
$4,075,407Alan A Aderem · Seattle Biomedical Research Institute · U19 · FY2014 · AI
Systems Genetics Approach to Determine Interactors of Apolipoprotein E in Alzheimerâs Disease
$4,075,379Michael Sasner · Jackson Laboratory · RF1 · FY2018 · AG
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$4,075,119Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
$4,074,684Joseph B. Margolick · Johns Hopkins University · U01 · FY2024 · HL
Global innate immune responses to HIV-1 infection
$4,074,664John A T Young · Salk Institute For Biological Studies · P01 · FY2011 · AI
Kansas IDeA Network of Biomedical Research Excellence
$4,073,893Douglas E Wright · University Of Kansas Medical Center · P20 · FY2014 · GM
FUNDAMENTAL CHEMISTRY AND PHYSICS OF DIRECT-ELECTROCHEMICAL OXIDATION IN SOLID-OXIDE FUEL CELLS
$4,072,455Trustees Of The Colorado School Of Mines · · FY2008 · Department of the Navy
Tau Pathology in CTE vs. Alzheimer's Disease: Microvasculopathy and Neuroinflammation
$4,071,754Ann Carolyn McKee · Boston University Medical Campus · RF1 · FY2017 · AG
Childhood Cancer Survivor Study
$4,071,218Gregory Armstrong · St. Jude Children'S Research Hospital · U24 · FY2014 · CA
Defects in Immunoregulatory Cell Receptors in Patients with LeukemiaLymphoma
$4,070,979Thomas A Waldmann · Clinical Sciences · Z01 · FY2007 · CA
THE PROJECT GOAL IS TO MEET DOE MEMBRANE AND ELECTRODE PERFORMANCE AND DURABILITY HEAVY-DUTY (HD) FUEL CELL TARGETS [END OF LIFE (EOL) OF 2.5 KW/GPGM AFTER 25,000 HEQV WITH =0.30 MGPGM/CM2 TOTAL LOADING] BY DEVELOPING NOVEL MEMBRANE-ELECTRODE ASSEMBLIES (MEAS) WITH THIN (SUB-NM TO SUB-ΜM THICK) SELECTIVE TRANSPORT (ST) LAYERS NEXT TO OR WITHIN THE PROTON EXCHANGE MEMBRANE (PEM).
$4,069,426General Motors Llc · · FY2025 · Department of Energy